AOD-9604 dosage protocols leverage this synthetic 16‑amino‑acid fragment (Tyr‑hGH 177–191) to support lipolysis (fat breakdown) and inhibit lipogenesis (fat storage) without elevating IGF‑1 levels or causing insulin resistance[1][2]. Clinical trials have demonstrated that AOD‑9604 exhibits a placebo‑like safety profile in obese adults, making it a well‑tolerated option for metabolic support[3]. This educational protocol outlines a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.
- 재구성: 3.0 mL의 세균 억제수를 추가하십시오 → ~0.667 mg/mL (667 mcg/mL) 농도.
- 일일 일반 범위: 하루에 300–500 mcg (점진적 증량).
- 쉬운 측정: 0.667 mg/mL에서 1 단위 = 0.01 mL ≈ 6.67 mcg는 U‑100 인슐린 주사기에 해당합니다.
- 저장: 동결 건조: −20 °C (−4 °F)에서 냉동; 재구성 후 2–8 °C (35.6–46.4 °F)에서 냉장; 동결-해동 사이클을 피하십시오.
